Received Jan 21, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 37AM2 | LA |
Pregnant patient at approximately 33 weeks gestation inadvertently received Arexvy (RSV vaccine not approved for use in pregnancy). Vaccine administered in error. Patient notified. No adverse maternal or fetal effects noted at time of report.